Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 55

1.

Nomogram to Predict the Benefit of Intensive Treatment for Locoregionally Advanced Head and Neck Cancer.

Mell LK, Shen H, Nguyen-Tân PF, Rosenthal DI, Zakeri K, Vitzthum LK, Frank SJ, Schiff PB, Trotti AM 3rd, Bonner JA, Jones CU, Yom SS, Thorstad WL, Wong SJ, Shenouda G, Ridge JA, Zhang QE, Le QT.

Clin Cancer Res. 2019 Dec 1;25(23):7078-7088. doi: 10.1158/1078-0432.CCR-19-1832. Epub 2019 Aug 16.

PMID:
31420360
2.

Cystic masses of the lateral neck: Diagnostic value comparison between fine-needle aspiration, core-needle biopsy, and frozen section.

Tabet P, Saydy N, Letourneau-Guillon L, Gologan O, Bissada É, Ayad T, Tabet JC, Guertin L, Nguyen-Tan PF, Christopoulos A.

Head Neck. 2019 Aug;41(8):2696-2703. doi: 10.1002/hed.25755. Epub 2019 Apr 4.

PMID:
30945785
3.

Validation of NRG oncology/RTOG-0129 risk groups for HPV-positive and HPV-negative oropharyngeal squamous cell cancer: Implications for risk-based therapeutic intensity trials.

Fakhry C, Zhang Q, Gillison ML, Nguyen-Tân PF, Rosenthal DI, Weber RS, Lambert L, Trotti AM 3rd, Barrett WL, Thorstad WL, Yom SS, Wong SJ, Ridge JA, Rao SSD, Spencer S, Fortin A, Raben D, Harris J, Le QT.

Cancer. 2019 Jun 15;125(12):2027-2038. doi: 10.1002/cncr.32025. Epub 2019 Mar 26.

PMID:
30913305
4.

Increased risk of oropharyngeal cancers mediated by oral human papillomavirus infection: Results from a Canadian study.

Laprise C, Madathil SA, Schlecht NF, Castonguay G, Soulières D, Nguyen-Tan PF, Allison P, Coutlée F, Hier M, Rousseau MC, Franco EL, Nicolau B.

Head Neck. 2019 Mar;41(3):678-685. doi: 10.1002/hed.25436. Epub 2019 Jan 3.

PMID:
30605251
5.

Dual-energy computed tomography for prediction of loco-regional recurrence after radiotherapy in larynx and hypopharynx squamous cell carcinoma.

Bahig H, Lapointe A, Bedwani S, de Guise J, Lambert L, Filion E, Roberge D, Létourneau-Guillon L, Blais D, Ng SP, Nguyen-Tan PF.

Eur J Radiol. 2019 Jan;110:1-6. doi: 10.1016/j.ejrad.2018.11.005. Epub 2018 Nov 5.

PMID:
30599844
6.

In Regard to Bossi et al.

Fakhry C, Nguyen-Tân PF, Lambert L, Rosenthal DI, Weber RS, Gillison ML, Trotti AM 3rd, Barrett WL, Thorstad WL, Jones CU, Yom SS, Wong SJ, Ridge JA, Rao SSD, Bonner JA, Vigneault E, Raben D, Kudrimoti MR, Harris J, Le QT.

Int J Radiat Oncol Biol Phys. 2018 Nov 1;102(3):669-670. doi: 10.1016/j.ijrobp.2018.06.020. No abstract available.

PMID:
30238902
7.

Pre-irradiation dental care: Ready-to-use templates for oropharyngeal cancers.

Jumeau R, Nguyen-Tan PF, Bahig H, Liem X, Lambert L, Schmittbuhl M, Simard D, Filion E.

Rep Pract Oncol Radiother. 2018 Jul-Aug;23(4):270-275. doi: 10.1016/j.rpor.2018.06.007. Epub 2018 Jul 26.

8.

Aetiological heterogeneity of head and neck squamous cell carcinomas: the role of human papillomavirus infections, smoking and alcohol.

Farsi NJ, Rousseau MC, Schlecht N, Castonguay G, Allison P, Nguyen-Tan PF, Souliéres D, Coutlée F, Hier M, Madathil S, Franco EL, Nicolau B.

Carcinogenesis. 2017 Dec 7;38(12):1188-1195. doi: 10.1093/carcin/bgx106.

PMID:
29029021
9.

Radiomics strategies for risk assessment of tumour failure in head-and-neck cancer.

Vallières M, Kay-Rivest E, Perrin LJ, Liem X, Furstoss C, Aerts HJWL, Khaouam N, Nguyen-Tan PF, Wang CS, Sultanem K, Seuntjens J, El Naqa I.

Sci Rep. 2017 Aug 31;7(1):10117. doi: 10.1038/s41598-017-10371-5.

10.

Four PTEN-targeting co-expressed miRNAs and ACTN4- targeting miR-548b are independent prognostic biomarkers in human squamous cell carcinoma of the oral tongue.

Berania I, Cardin GB, Clément I, Guertin L, Ayad T, Bissada E, Nguyen-Tan PF, Filion E, Guilmette J, Gologan O, Soulieres D, Rodier F, Wong P, Christopoulos A.

Int J Cancer. 2017 Dec 1;141(11):2318-2328. doi: 10.1002/ijc.30915. Epub 2017 Aug 18.

11.

Development and Validation of Nomograms Predictive of Overall and Progression-Free Survival in Patients With Oropharyngeal Cancer.

Fakhry C, Zhang Q, Nguyen-Tân PF, Rosenthal DI, Weber RS, Lambert L, Trotti AM 3rd, Barrett WL, Thorstad WL, Jones CU, Yom SS, Wong SJ, Ridge JA, Rao SSD, Bonner JA, Vigneault E, Raben D, Kudrimoti MR, Harris J, Le QT, Gillison ML.

J Clin Oncol. 2017 Dec 20;35(36):4057-4065. doi: 10.1200/JCO.2016.72.0748. Epub 2017 Aug 4.

12.

Human papillomavirus genotypes and risk of head and neck cancers: Results from the HeNCe Life case-control study.

Laprise C, Madathil SA, Schlecht NF, Castonguay G, Soulières D, Nguyen-Tan PF, Allison P, Coutlée F, Hier M, Rousseau MC, Franco EL, Nicolau B.

Oral Oncol. 2017 Jun;69:56-61. doi: 10.1016/j.oraloncology.2017.03.013. Epub 2017 Apr 10.

PMID:
28559021
13.

Larynx motion considerations in partial larynx volumetric modulated arc therapy for early glottic cancer.

Bahig H, Nguyen-Tan PF, Filion É, Roberge D, Thanomsack P, de Guise J, Blais D, Doucet R, Létourneau-Guillon L, Lambert L.

J Med Imaging Radiat Oncol. 2017 Oct;61(5):666-673. doi: 10.1111/1754-9485.12612. Epub 2017 May 30.

PMID:
28557310
14.

The KRAS-Variant and Cetuximab Response in Head and Neck Squamous Cell Cancer: A Secondary Analysis of a Randomized Clinical Trial.

Weidhaas JB, Harris J, Schaue D, Chen AM, Chin R, Axelrod R, El-Naggar AK, Singh AK, Galloway TJ, Raben D, Wang D, Matthiesen C, Avizonis VN, Manon RR, Yumen O, Nguyen-Tan PF, Trotti A, Skinner H, Zhang Q, Ferris RL, Sidransky D, Chung CH.

JAMA Oncol. 2017 Apr 1;3(4):483-491. doi: 10.1001/jamaoncol.2016.5478.

15.

Exploratory Factor Analysis of NRG Oncology's University of Washington Quality of Life Questionnaire-RTOG Modification.

Pugh SL, Wyatt G, Wong RK, Sagar SM, Yueh B, Singh AK, Yao M, Nguyen-Tan PF, Yom SS, Cardinale FS, Sultanem K, Hodson DI, Krempl GA, Chavez A, Yeh AM, Bruner DW.

J Pain Symptom Manage. 2017 Jan;53(1):139-145.e2. doi: 10.1016/j.jpainsymman.2016.11.002. Epub 2016 Nov 27.

16.

Quality of Life and Performance Status From a Substudy Conducted Within a Prospective Phase 3 Randomized Trial of Concurrent Accelerated Radiation Plus Cisplatin With or Without Cetuximab for Locally Advanced Head and Neck Carcinoma: NRG Oncology Radiation Therapy Oncology Group 0522.

Truong MT, Zhang Q, Rosenthal DI, List M, Axelrod R, Sherman E, Weber R, Nguyen-Tân PF, El-Naggar A, Konski A, Galvin J, Schwartz D, Trotti A, Silverman C, Singh A, Godette K, Bonner JA, Jones CU, Garden AS, Shenouda G, Matthiesen C, Le QT, Bruner D.

Int J Radiat Oncol Biol Phys. 2017 Mar 15;97(4):687-699. doi: 10.1016/j.ijrobp.2016.08.003. Epub 2016 Aug 12.

17.

Quality of Life and Performance Status From a Substudy Conducted Within a Prospective Phase 3 Randomized Trial of Concurrent Standard Radiation Versus Accelerated Radiation Plus Cisplatin for Locally Advanced Head and Neck Carcinoma: NRG Oncology RTOG 0129.

Xiao C, Zhang Q, Nguyen-Tân PF, List M, Weber RS, Ang KK, Rosenthal D, Filion EJ, Kim H, Silverman C, Raben A, Galloway T, Fortin A, Gore E, Winquist E, Jones CU, Robinson W, Raben D, Le QT, Bruner D.

Int J Radiat Oncol Biol Phys. 2017 Mar 15;97(4):667-677. doi: 10.1016/j.ijrobp.2016.07.020. Epub 2016 Jul 25.

18.

Prognostic Value of p16 Status on the Development of a Complete Response in Involved Oropharynx Cancer Neck Nodes After Cisplatin-Based Chemoradiation: A Secondary Analysis of NRG Oncology RTOG 0129.

Galloway TJ, Zhang QE, Nguyen-Tan PF, Rosenthal DI, Soulieres D, Fortin A, Silverman CL, Daly ME, Ridge JA, Hammond JA, Le QT.

Int J Radiat Oncol Biol Phys. 2016 Oct 1;96(2):362-371. doi: 10.1016/j.ijrobp.2016.05.026. Epub 2016 May 28.

19.

Palliative Radiation Therapy for Advanced Head and Neck Carcinomas: A Phase 2 Study.

Fortin B, Khaouam N, Filion E, Nguyen-Tan PF, Bujold A, Lambert L.

Int J Radiat Oncol Biol Phys. 2016 Jun 1;95(2):647-53. doi: 10.1016/j.ijrobp.2016.01.039. Epub 2016 Jan 28.

PMID:
27020111
20.

Xerostomia health-related quality of life: NRG oncology RTOG 0537.

Wyatt G, Pugh SL, Wong RK, Sagar S, Singh AK, Koyfman SA, Nguyen-Tân PF, Yom SS, Cardinale FS, Sultanem K, Hodson I, Krempl GA, Lukaszczyk B, Yeh AM, Berk L.

Qual Life Res. 2016 Sep;25(9):2323-33. doi: 10.1007/s11136-016-1255-0. Epub 2016 Feb 25.

21.

Acupuncture-Like Transcutaneous Electrical Nerve Stimulation Versus Pilocarpine in Treating Radiation-Induced Xerostomia: Results of RTOG 0537 Phase 3 Study.

Wong RK, Deshmukh S, Wyatt G, Sagar S, Singh AK, Sultanem K, Nguyen-Tân PF, Yom SS, Cardinale J, Yao M, Hodson I, Matthiesen CL, Suh J, Thakrar H, Pugh SL, Berk L.

Int J Radiat Oncol Biol Phys. 2015 Jun 1;92(2):220-7. doi: 10.1016/j.ijrobp.2015.01.050. Epub 2015 Apr 1.

22.

Reply to B. O'Sullivan et Al.

Fakhry C, Zhang Q, Nguyen-Tan PF, Rosenthal D, El-Naggar AK, Garden AS, Soulieres D, Trotti A, Avizonis VN, Ridge JA, Harris J, Le QT, Gillison M.

J Clin Oncol. 2015 May 20;33(15):1708-9. doi: 10.1200/JCO.2014.60.3555. Epub 2015 Mar 30. No abstract available.

PMID:
25823732
23.

Predictive factors of survival and treatment tolerance in older patients treated with chemotherapy and radiotherapy for locally advanced head and neck cancer.

Bahig H, Fortin B, Alizadeh M, Lambert L, Filion E, Guertin L, Ayad T, Christopoulos A, Bissada E, Soulières D, Gaba Idiamey F, Nguyen-Tan PF.

Oral Oncol. 2015 May;51(5):521-8. doi: 10.1016/j.oraloncology.2015.02.097. Epub 2015 Mar 18.

PMID:
25797461
24.

Reply to D. Adkins et al.

Axelrod RS, Sherman E, Garden A, Nguyen-Tan PF, Trotti A, Yom SS, Zhang Q.

J Clin Oncol. 2015 Apr 1;33(10):1224-5. doi: 10.1200/JCO.2014.59.9431. Epub 2015 Feb 23. No abstract available.

PMID:
25713438
25.

Institutional clinical trial accrual volume and survival of patients with head and neck cancer.

Wuthrick EJ, Zhang Q, Machtay M, Rosenthal DI, Nguyen-Tan PF, Fortin A, Silverman CL, Raben A, Kim HE, Horwitz EM, Read NE, Harris J, Wu Q, Le QT, Gillison ML.

J Clin Oncol. 2015 Jan 10;33(2):156-64. doi: 10.1200/JCO.2014.56.5218. Epub 2014 Dec 8.

26.

Predicting depression and quality of life among long-term head and neck cancer survivors.

Moubayed SP, Sampalis JS, Ayad T, Guertin L, Bissada E, Gologan OE, Soulières D, Lambert L, Filion E, Nguyen-Tan PF, Christopoulos A.

Otolaryngol Head Neck Surg. 2015 Jan;152(1):91-7. doi: 10.1177/0194599814557772. Epub 2014 Nov 13.

PMID:
25395572
27.

Randomized phase III trial to test accelerated versus standard fractionation in combination with concurrent cisplatin for head and neck carcinomas in the Radiation Therapy Oncology Group 0129 trial: long-term report of efficacy and toxicity.

Nguyen-Tan PF, Zhang Q, Ang KK, Weber RS, Rosenthal DI, Soulieres D, Kim H, Silverman C, Raben A, Galloway TJ, Fortin A, Gore E, Westra WH, Chung CH, Jordan RC, Gillison ML, List M, Le QT.

J Clin Oncol. 2014 Dec 1;32(34):3858-66. doi: 10.1200/JCO.2014.55.3925. Epub 2014 Nov 3.

28.

Randomized phase III trial of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III to IV head and neck carcinoma: RTOG 0522.

Ang KK, Zhang Q, Rosenthal DI, Nguyen-Tan PF, Sherman EJ, Weber RS, Galvin JM, Bonner JA, Harris J, El-Naggar AK, Gillison ML, Jordan RC, Konski AA, Thorstad WL, Trotti A, Beitler JJ, Garden AS, Spanos WJ, Yom SS, Axelrod RS.

J Clin Oncol. 2014 Sep 20;32(27):2940-50.

29.

North-American survey on HPV-DNA and p16 testing for head and neck squamous cell carcinoma.

Maniakas A, Moubayed SP, Ayad T, Guertin L, Nguyen-Tan PF, Gologan O, Soulieres D, Christopoulos A.

Oral Oncol. 2014 Oct;50(10):942-6. doi: 10.1016/j.oraloncology.2014.07.004. Epub 2014 Aug 2.

PMID:
25096827
30.

Human papillomavirus and overall survival after progression of oropharyngeal squamous cell carcinoma.

Fakhry C, Zhang Q, Nguyen-Tan PF, Rosenthal D, El-Naggar A, Garden AS, Soulieres D, Trotti A, Avizonis V, Ridge JA, Harris J, Le QT, Gillison M.

J Clin Oncol. 2014 Oct 20;32(30):3365-73. doi: 10.1200/JCO.2014.55.1937. Epub 2014 Jun 23.

31.

Risk factors for clinician-reported symptom clusters in patients with advanced head and neck cancer in a phase 3 randomized clinical trial: RTOG 0129.

Xiao C, Hanlon A, Zhang Q, Movsas B, Ang K, Rosenthal DI, Nguyen-Tan PF, Kim H, Le Q, Bruner DW.

Cancer. 2014 Mar 15;120(6):848-54. doi: 10.1002/cncr.28500. Epub 2013 Dec 11.

32.

Xerostomia in patients treated for oropharyngeal carcinoma: comparing linear accelerator-based intensity-modulated radiation therapy with helical tomotherapy.

Fortin I, Fortin B, Lambert L, Clavel S, Alizadeh M, Filion EJ, Soulières D, Bélair M, Guertin L, Nguyen-Tan PF.

Head Neck. 2014 Sep;36(9):1343-8. doi: 10.1002/hed.23463. Epub 2013 Dec 17.

PMID:
24038408
33.

Prevalence of K-RAS Codons 12 and 13 Mutations in Locally Advanced Head and Neck Squamous Cell Carcinoma and Impact on Clinical Outcomes.

Bissada E, Abboud O, Abou Chacra Z, Guertin L, Weng X, Nguyen-Tan PF, Tabet JC, Thibaudeau E, Lambert L, Audet ML, Fortin B, Soulières D.

Int J Otolaryngol. 2013;2013:848021. doi: 10.1155/2013/848021. Epub 2013 Apr 30.

34.

Symptom clusters in patients with head and neck cancer receiving concurrent chemoradiotherapy.

Xiao C, Hanlon A, Zhang Q, Ang K, Rosenthal DI, Nguyen-Tan PF, Kim H, Movsas B, Bruner DW.

Oral Oncol. 2013 Apr;49(4):360-6. doi: 10.1016/j.oraloncology.2012.10.004. Epub 2012 Nov 17.

35.

A phase II trial of dacomitinib, an oral pan-human EGF receptor (HER) inhibitor, as first-line treatment in recurrent and/or metastatic squamous-cell carcinoma of the head and neck.

Abdul Razak AR, Soulières D, Laurie SA, Hotte SJ, Singh S, Winquist E, Chia S, Le Tourneau C, Nguyen-Tan PF, Chen EX, Chan KK, Wang T, Giri N, Mormont C, Quinn S, Siu LL.

Ann Oncol. 2013 Mar;24(3):761-9. doi: 10.1093/annonc/mds503. Epub 2012 Oct 28.

PMID:
23108949
36.

Prognostic value of cartilage sclerosis in laryngeal cancer treated with primary radiation therapy.

Moubayed SP, Bélair M, Saliba J, Bibeau-Poirier J, Christopoulos A, Nguyen-Tan PF, Guertin L, Lambert L, Olivier MJ, Ayad T.

Otolaryngol Head Neck Surg. 2012 Jul;147(1):57-62. doi: 10.1177/0194599812438181. Epub 2012 Feb 21.

PMID:
22357645
37.

Phase 2 results from Radiation Therapy Oncology Group Study 0537: a phase 2/3 study comparing acupuncture-like transcutaneous electrical nerve stimulation versus pilocarpine in treating early radiation-induced xerostomia.

Wong RK, James JL, Sagar S, Wyatt G, Nguyen-Tân PF, Singh AK, Lukaszczyk B, Cardinale F, Yeh AM, Berk L.

Cancer. 2012 Sep 1;118(17):4244-52. doi: 10.1002/cncr.27382. Epub 2012 Jan 17.

38.

¹⁸F-FDG-PET imaging in radiotherapy tumor volume delineation in treatment of head and neck cancer.

Delouya G, Igidbashian L, Houle A, Bélair M, Boucher L, Cohade C, Beaulieu S, Filion EJ, Coulombe G, Hinse M, Martel C, Després P, Nguyen-Tan PF.

Radiother Oncol. 2011 Dec;101(3):362-8. doi: 10.1016/j.radonc.2011.07.025. Epub 2011 Aug 30.

PMID:
21885143
39.

Cervical lymph node metastases from unknown primary cancer: a single-institution experience with intensity-modulated radiotherapy.

Villeneuve H, Després P, Fortin B, Filion E, Donath D, Soulières D, Guertin L, Ayad T, Christopoulos A, Nguyen-Tan PF.

Int J Radiat Oncol Biol Phys. 2012 Apr 1;82(5):1866-71. doi: 10.1016/j.ijrobp.2011.02.031. Epub 2011 Apr 15.

PMID:
21497452
40.

The role of computed tomography in the management of the neck after chemoradiotherapy in patients with head-and-neck cancer.

Clavel S, Charron MP, Bélair M, Delouya G, Fortin B, Després P, Soulières D, Filion E, Guertin L, Nguyen-Tan PF.

Int J Radiat Oncol Biol Phys. 2012 Feb 1;82(2):567-73. doi: 10.1016/j.ijrobp.2010.11.066. Epub 2011 Feb 9.

PMID:
21310545
41.

Simultaneous integrated boost using intensity-modulated radiotherapy compared with conventional radiotherapy in patients treated with concurrent carboplatin and 5-fluorouracil for locally advanced oropharyngeal carcinoma.

Clavel S, Nguyen DH, Fortin B, Després P, Khaouam N, Donath D, Soulières D, Guertin L, Nguyen-Tan PF.

Int J Radiat Oncol Biol Phys. 2012 Feb 1;82(2):582-9. doi: 10.1016/j.ijrobp.2010.10.061. Epub 2011 Feb 1.

PMID:
21277695
42.

Human papillomavirus and survival of patients with oropharyngeal cancer.

Ang KK, Harris J, Wheeler R, Weber R, Rosenthal DI, Nguyen-Tân PF, Westra WH, Chung CH, Jordan RC, Lu C, Kim H, Axelrod R, Silverman CC, Redmond KP, Gillison ML.

N Engl J Med. 2010 Jul 1;363(1):24-35. doi: 10.1056/NEJMoa0912217. Epub 2010 Jun 7.

43.

Enteral feeding during chemoradiotherapy for advanced head-and-neck cancer: a single-institution experience using a reactive approach.

Clavel S, Fortin B, Després P, Donath D, Soulières D, Khaouam N, Charpentier D, Bélair M, Guertin L, Nguyen-Tan PF.

Int J Radiat Oncol Biol Phys. 2011 Mar 1;79(3):763-9. doi: 10.1016/j.ijrobp.2009.12.032. Epub 2010 May 24.

PMID:
20510546
44.

Outcome with neck dissection after chemoradiation for N3 head-and-neck squamous cell carcinoma.

Igidbashian L, Fortin B, Guertin L, Soulières D, Coulombe G, Belair M, Charpentier D, Tabet JC, Nguyen-Tan PF.

Int J Radiat Oncol Biol Phys. 2010 Jun 1;77(2):414-20. doi: 10.1016/j.ijrobp.2009.05.034. Epub 2009 Sep 21.

PMID:
19775825
45.

Concurrent chemoradiation with carboplatin-5-fluorouracil versus cisplatin in locally advanced oropharyngeal cancers: is more always better?

Barkati M, Fortin B, Soulières D, Clavel S, Després P, Charpentier D, Tabet JC, Guertin L, Olivier MJ, Coulombe G, Donath D, Nguyen-Tan PF.

Int J Radiat Oncol Biol Phys. 2010 Feb 1;76(2):410-6. doi: 10.1016/j.ijrobp.2009.02.034. Epub 2009 May 8.

PMID:
19427745
46.

Organ preservation with concurrent chemoradiation for advanced laryngeal cancer: are we succeeding?

Lambert L, Fortin B, Soulières D, Guertin L, Coulombe G, Charpentier D, Tabet JC, Bélair M, Khaouam N, Nguyen-Tan PF.

Int J Radiat Oncol Biol Phys. 2010 Feb 1;76(2):398-402. doi: 10.1016/j.ijrobp.2009.01.058. Epub 2009 Apr 23.

PMID:
19394155
47.

Neck dissection following concurrent chemoradiation for advanced head and neck carcinoma: pathologic findings and complications.

Christopoulos A, Nguyen-Tan PF, Tabet JC, Fortin B, Souliàres D, Charpentier D, Guertin L.

J Otolaryngol Head Neck Surg. 2008 Aug;37(4):452-6.

PMID:
19128575
48.

Controversies in the management of retromolar trigone carcinoma.

Ayad T, Guertin L, Soulières D, Belair M, Temam S, Nguyen-Tân PF.

Head Neck. 2009 Mar;31(3):398-405. doi: 10.1002/hed.20956. Review.

PMID:
19031403
49.

Phase 2 study of silver leaf dressing for treatment of radiation-induced dermatitis in patients receiving radiotherapy to the head and neck.

Vavassis P, Gelinas M, Chabot Tr J, Nguyen-Tân PF.

J Otolaryngol Head Neck Surg. 2008 Feb;37(1):124-9.

PMID:
18479639
50.

Impact of massage therapy on anxiety levels in patients undergoing radiation therapy: randomized controlled trial.

Campeau MP, Gaboriault R, Drapeau M, Van Nguyen T, Roy I, Fortin B, Marois M, Nguyen-Tân PF.

J Soc Integr Oncol. 2007 Fall;5(4):133-8.

PMID:
19087756

Supplemental Content

Loading ...
Support Center